RUBIN EYAL (Sr. VP & CFO) received a stock award from PROTALIX BIOTHERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/13/2020ACC: 0001104659-20-094755
Officer· Sr. VP & CFO
Since Sep 2019
+246.15K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
246.15K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+246.15K
Price / share
—
Trade value
—
% of position
New position
8/11/2020
0.00→246.15K
Total
Net shares
+246.15K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/11/2020 | A · Award | +246.15K | — | — | New position | 0.00 | 246.15K |
| Total | +246.15K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported